Clinical Trial Update: The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing i-FACTOR, a peptide-enhanced bone graft substitute, versus Allograft in elderly patients undergoing posterolateral spinal fusio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Spondylolisthesis
• Spinal Stenosis

Drugs mentioned

• Allograft
• i-FACTOR (P-15 peptide-enhanced bone graft substitute)

Snippet

Sponsor: Sygehus Lillebaelt | Conditions: Spinal Stenosis | Phase 3 | Status: UNKNOWN